Bank of New York Mellon Corp
BankPosition in RARE — Ultragenyx Pharmaceutical Inc.
CIK 1390777
NEW YORK, NY
Position in RARE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$15,716,569
+$8,570,006 QoQ
Shares Held
470,697
+38.0% QoQ
Ownership
0.477%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. RARE ranks #50 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in RARE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,716,569 | 470,697 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $7,146,563 | 341,125 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $6,870,238 | 298,706 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $9,771,333 | 324,845 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $17,230,524 | 473,887 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $25,207,981 | 696,161 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $31,088,588 | 738,973 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $42,889,315 | 772,085 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $32,137,851 | 781,943 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $42,565,212 | 911,656 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $48,337,884 | 1,010,830 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $22,163,813 | 621,706 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $29,660,937 | 642,986 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $26,133,566 | 651,710 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $30,195,293 | 651,744 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $30,465,744 | 735,710 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $47,371,945 | 794,032 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $54,830,416 | 755,032 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $71,438,065 | 849,543 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $77,955,272 | 864,345 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $81,987,361 | 859,857 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $93,583,237 | 821,915 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $105,017,421 | 758,632 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $63,482,648 | 772,389 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $59,067,750 | 755,149 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $31,297,201 | 704,416 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||